Cargando…
Promising Lead Compounds in the Development of Potential Clinical Drug Candidate for Drug-Resistant Tuberculosis
According to WHO report, globally about 10 million active tuberculosis cases, resulting in about 1.6 million deaths, further aggravated by drug-resistant tuberculosis and/or comorbidities with HIV and diabetes are present. Incomplete therapeutic regimen, meager dosing, and the capability of the late...
Autores principales: | Alghamdi, Saad, Rehman, Shaheed Ur, Shesha, Nashwa Talaat, Faidah, Hani, Khurram, Muhammad, Rehman, Sabi Ur |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729780/ https://www.ncbi.nlm.nih.gov/pubmed/33276545 http://dx.doi.org/10.3390/molecules25235685 |
Ejemplares similares
-
COVID-19 challenges and its therapeutics
por: Rehman, Sabi Ur, et al.
Publicado: (2021) -
Phenolic Compounds as Promising Drug Candidates in Tuberculosis Therapy
por: Mazlun, Muhamad Harith, et al.
Publicado: (2019) -
In Vitro Assessment of CYP-Mediated Drug Interactions for Kinsenoside, an Antihyperlipidemic Candidate
por: Rehman, Shaheed Ur, et al.
Publicado: (2016) -
Therapeutic development by repurposing drugs targeting SARS-CoV-2 spike protein interactions by simulation studies
por: Jamal, Qazi Mohammad Sajid, et al.
Publicado: (2021) -
Nanoparticles: Synthesis and Their Role as Potential Drug Candidates for the Treatment of Parasitic Diseases
por: Bajwa, Hammad Ur Rehman, et al.
Publicado: (2022)